|
Net income
|
|
$11.1m
|
$1.3m
|
($2.8m)
|
$46k
|
$31.6m
|
|
Depreciation and amortization
|
|
$1.4m
|
$2.2m
|
$3.0m
|
$3.6m
|
$3.7m
|
|
Amortization of debt issuance costs
|
|
$222k
|
$589k
|
$794k
|
$819k
|
$833k
|
|
Deferred income taxes
|
|
—
|
($743k)
|
$721k
|
($2.9m)
|
$4.0m
|
|
Share-based compensation expense
|
|
—
|
$82.2m
|
$9.1m
|
$8.7m
|
$8.9m
|
|
Operating lease liabilities
|
|
($239k)
|
($219k)
|
($397k)
|
($762k)
|
($523k)
|
|
Bad debt expense
|
|
$240k
|
($155k)
|
$663k
|
$1.5m
|
$1.7m
|
|
Provision for obsolete inventory
|
|
$471k
|
$140k
|
($26k)
|
$503k
|
$2.0m
|
|
Non-cash lease expense
|
|
$226k
|
$240k
|
$499k
|
$815k
|
$545k
|
|
Non-cash interest on share repurchase liability
|
|
—
|
—
|
—
|
$2.6m
|
$3.2m
|
|
(Gain) loss from change in fair value of earnout liabilities
|
|
—
|
($61.8m)
|
$9.0m
|
$19.6m
|
($13.0m)
|
|
Accounts receivable
|
|
($752k)
|
($1.6m)
|
($505k)
|
($2.3m)
|
($958k)
|
|
Inventory
|
|
($5.8m)
|
($1.7m)
|
($6.1m)
|
$3.7m
|
($6.2m)
|
|
Other assets
|
|
$34k
|
($2.3m)
|
($5.4m)
|
$2.9m
|
$1.7m
|
|
Accounts payable
|
|
$281k
|
$416k
|
($165k)
|
$1.5m
|
$1.0m
|
|
Deferred revenue
|
|
($373k)
|
$384k
|
$1.4m
|
$190k
|
($400k)
|
|
Accrued expenses
|
|
$1.8m
|
($30.8m)
|
$2.2m
|
$4.6m
|
($2.7m)
|
|
Payments pursuant to TRA
|
|
—
|
—
|
—
|
—
|
($93k)
|
|
Purchases of property and equipment
|
|
($1.4m)
|
($333k)
|
($359k)
|
($6.4m)
|
($5.0m)
|
|
Purchases of capitalized software
|
|
($2.4m)
|
($1.5m)
|
($2.4m)
|
($526k)
|
($1.8m)
|
|
Acquisitions, net of cash acquired
|
|
—
|
—
|
—
|
($11.8m)
|
—
|
|
Borrowings on revolving loans
|
|
—
|
—
|
—
|
—
|
$5.0m
|
|
Principal repayments on term loan
|
|
($5.0m)
|
($4.4m)
|
($6.2m)
|
($6.2m)
|
($6.2m)
|
|
Payments on repurchase liability
|
|
—
|
—
|
—
|
($62.2m)
|
($37.6m)
|
|
Proceeds from exercise of stock options
|
|
—
|
—
|
$420k
|
$2.4m
|
$226k
|
|
Issuance of stock under purchase plan
|
|
—
|
—
|
$144k
|
$282k
|
$142k
|
|
Distributions
|
|
($11.4m)
|
($12.9m)
|
($8.7m)
|
($4.7m)
|
($1.7m)
|
|
Capital expenditures and capitalized software included in accounts payable
|
|
$282k
|
$49k
|
$208k
|
$50k
|
—
|
|
Shares issued to acquire Simpatra
|
|
—
|
—
|
—
|
$1.8m
|
—
|
|
Net cash provided by operating activities
|
|
($1.4m)
|
($9.2m)
|
$26.9m
|
$45.2m
|
$35.2m
|
|
Net cash used in investing activities
|
|
($317.5m)
|
($1.8m)
|
($2.7m)
|
($18.8m)
|
($6.9m)
|
|
Repurchases of Class A common stock
|
|
—
|
—
|
—
|
($5.6m)
|
($3.4m)
|
|
Net cash used in financing activities
|
|
$319.0m
|
$63.5m
|
($14.4m)
|
($76.1m)
|
($43.6m)
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
($12k)
|
—
|
($19k)
|
($22k)
|
$6k
|
|
Net decrease in cash and cash equivalents
|
|
$9.6m
|
$52.5m
|
$9.8m
|
($49.7m)
|
($15.2m)
|
|
Cash and cash equivalents at beginning of period
|
|
$26.8m
|
$79.2m
|
$89.0m
|
$39.3m
|
$24.1m
|
|
Cash paid for interest
|
|
$1.5m
|
$4.4m
|
$9.5m
|
$9.5m
|
$7.9m
|
|
Cash paid for income taxes
|
|
$171k
|
$282k
|
$4.4m
|
$2.6m
|
$2.8m
|